Cronos Group Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Cronos Group Inc. is a global cannabinoid company focused on building disruptive intellectual property through advancing cannabis research, technology and product development. The company offers a portfolio of cannabis and cannabis-derived products including dried flower, pre-rolls, edibles, vapes, oils, vaporizers, concentrates and tinctures under brands such as Spinach, PEACE NATURALS, Lord Jones and Cove; it targets adult-use recreational markets in Canada and medical markets in Israel through regulated channels like provincial distributors and pharmacies. Founded in 2012 and headquartered in Toronto, Ontario, Canada, Cronos Group operates an asset-light model emphasizing brand development, innovation in rare cannabinoids via biosynthesis partnerships like Ginkgo Bioworks, and geographic diversification across North America, Israel and select international markets. Recent developments include obtaining majority board control of Cronos GrowCo in July 2024 to expand cultivation capacity by 70% with completion targeted for Q2 2025 and initial sales in the second half of the year; providing C$30 million in convertible debt financing to High Tide Inc. in July 2025 to support retail ecosystem growth; and reporting Q3 2025 net revenue of $19.5 million with ongoing focus on margin expansion and flower supply improvements into 2026.
3 Canadian Marijuana Stocks That Could Help You Make Money
Top Canadian Marijuana Stock Choices For Better Investing In 2026
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Cronos Group Q1 Earnings Call Highlights
Cronos Group (CRON) Q1 Earnings Meet Estimates
Cronos Group Reports 2026 First Quarter Results
Cronos Group Reports 2026 First Quarter Results
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison
Incannex Healthcare (NASDAQ:IXHL) and Cronos Group (NASDAQ:CRON) Financial Contrast
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
Financial Comparison: Cronos Group (NASDAQ:CRON) & Kiora Pharmaceuticals (NASDAQ:KPRX)
3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026
Top Canadian Marijuana Stocks To Watch This Month For Better Trading
Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript